Physio-Control’s LIFEPAK 15 Now Approved for Use in Canada
Finally, the Physio-Control LIFEPACK 15 monitor/defibrillator has received market approval in Canada. The official notification, granted by Health Canada, was issued on September 1, 2009. In addition, the company was granted the CE mark of approval in January 2009, signifying its compliance with EU standards for medical devices, just before it started marketing the LIFEPAK 15 in the U.S. earlier this year.
Building on Physio-Control’s 54 year heritage of providing the most innovative medical equipment for lifesaving, the LIFEPAK 15 offers an all-new platform of best-in-class functionality. It definitely raises the bar for industry standards of reliability and durability.
One of the most significant ways that the LIFEPAK 15 stays ahead of competitors is by being the first monitor / defibrillator to introduce Masimo Rainbow SET® Pulse CO- Oximetry™ for the detection of carbon monoxide in the blood and methemoglobin in the blood (a result of exposure to certain drugs and chemicals).
The new design is focused upon several innovative functions, including the biggest color screen available, and a single button that changes the screen to a high-contrast mode for better viewing in bright sunlight. In addition, the LIFEPAK 15 offers ten times the processing speed as its predecessor and triples its battery life. Because the monitor/defibrillators are often used in harsh environments, they are built tougher than any other model on the market.
Now that the LIFEPAK 15 is available in Canada, many hospitals are expected to transition their existing medical equipment as budgets permit. Its durability, reliability, functionality and ease-of-use make the LIFEPAK 15 an excellent way for health care institutions to reduce their operational expenses while minimizing training costs.